|
What’s in a name? That which we call IPF, by any other name would act the same
|
29-05-2018 |
|
Diffuse parenchymal lung disease
|
30-05-2017 |
|
Changes in the respiratory microbioma during acute exacerbations of idiopathic pulmonary fibrosis
|
18-04-2017 |
|
Clinical impact of the interstitial lung disease multidisciplinary service
|
23-11-2016 |
|
Therapeutic Approach to Adult Fibrotic Lung Diseases
|
20-10-2016 |
|
Nonspecific Interstitial Pneumonia: what is the optimal approach management?
|
18-07-2016 |
|
European IPF Patient Charter: an SOS to the world
|
04-03-2016 |
|
Bronchoscopic lung cryobiopsy increases diagnostic confidence in multidisciplinary diagnosis of idiopathic pulmonary fibrosis
|
08-01-2016 |
|
Fibrosing interstitial lung diseases involve different pathogenetic pathways with similar outcomes
|
09-10-2015 |
|
Critically ill patients with interstitial lung disease
|
31-08-2015 |
|
Air pollution exposure: a novel environmental risk factor for interstitial lung disease?
|
21-05-2015 |
|
CT findings of probable UIP have a high predictive value for histologic UIP
|
07-01-2015 |
|
Interstitial lung disease in connective tissue disease-mechanism and management
|
13-10-2014 |
|
Brensocatib in non-cystic fibrosis bronchiectasis: ASPEN protocol and baseline characteristic
|
20-05-2025 |
|
Antibiotici inalatori nelle bronchiectasie non da Fibrosi Cistica con infezione cronica da Pseudomonas Aeruginosa: quali, come e perché
|
22-04-2025 |
|
Cathepsin C (dipeptidyl peptidase 1) inhibition in adults with bronchiectasis: AIRLEAF, a phase II randomised, double-blind, placebo-controlled, dose-finding study
|
28-01-2025 |
|
Aspergillosi broncopolmonare allergica: novità introdotte dalle linee guida ISHAM-ABPA 2024
|
30-09-2024 |
|
The paradox of the safer cigarette: understanding the pulmonary effects of electronic cigarettes
|
28-08-2024 |
|
Efficacy and safety of a bivalent RSV perfusion F vaccine in older adults
|
16-07-2024 |
|
Endotypes in bronchiectasis: moving towards precision medicine. A narrative review
|
07-05-2024 |
|
AMR-Lung: a European clinical research collaboration on antimicrobial resistance in chronic lung disease
|
20-03-2024 |
|
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia
|
26-09-2018 |
|
Duration of antibiotic therapy for patients with bacteremic Staphylococcus aureus Community-Acquired Pneumonia
|
07-05-2018 |
|
European Respiratory Society guidelines for the management of adult bronchiectasis
|
09-11-2017 |
|
Duration of antibiotic treatment in community-acquired pneumonia: a multicenter randomized clinical trial
|
30-08-2017 |
|
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society guideline.
|
02-02-2017 |
|
Staphylococcus aureus community-acquired pneumonia: prevalence, clinical characteristics, and outcomes
|
09-01-2017 |
|
Effect of corticosteroids on treatment failure among hospitalized patients with severe community-acquired pneumonia and high inflammatory response: a randomized clinical trial
|
17-10-2016 |
|
Clinical phenotypes in adult patients with bronchiectasis
|
29-07-2016 |
|
Macrolide effects on the prevention of COPD exacerbations
|
23-05-2013 |
|
Predictive factors, microbiology and outcome of patients with parapneumonic effusion
|
13-06-2012 |
|
Three Months of Rifapentine and Isoniazid for Latent Tuberculosis Infection
|
17-01-2012 |
|
Observational Study of Inhaled Corticosteroids on Outcomes for COPD Patients with Pneumonia
|
28-11-2011 |
|
Role of atypical pathogens among adult hospitalized patients with community - acquired pneumonia
|
19-04-2011 |
|
Single and multiple viral infections in lower respiratory tract infection
|
15-12-2010 |
|
Community-acquired pneumonia through Enterobacteriaceae and Pseudomonas aeruginosa: diagnosis, incidence and predictors
|
07-09-2010 |
|
Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
|
19-05-2010 |
|
MRSA as a cause of community-acquired pneumonia
|
15-03-2010 |
|
Rapid diagnostic testing for community-acquired pneumonia: can innovative technology for clinical microbiology be exploited?
|
09-03-2010 |
|
Long-term Erythromycin Therapy Is Associated with Decreased Chronic Obstructive Pulmonary Disease Exacerbations
|
05-11-2009 |
|
Community - acquired pneumonia
|
09-09-2009 |
|
Il ruolo dell’ecografia toracica nel riconoscimento del fallimento delle strategie di supporto non invasivo nel paziente con insufficienza respiratoria acuta ipossiemica
|
24-03-2026 |
